Automated Confocal Microscopy
BD Pathway 855 High-Content Bioimager
Fluofarma owns a High Content Screening platform based on automated confocal
microscopy. This innovative platform enables real-time confocal imaging
with high quality images.
► Automated Platform: from liquid
handling to data analysis
► Versatility and flexibility:
- Multiple slide and multiwell plate formats
- Fixed cells, suspension or loosely
adherent cells
- Controlled imaging chamber for live cell
experimentation
- Laser-free illumination, large spectrum
of fluorescent dyes
► Fast and efficient:
- High quality images and reduced background
fluorescence
- Easy conversion of endpoint assays to
kinetic applications
- Flexible software: easy data
classification & analysis
Breaking news
Scientific Publication
Fluofarma is glad to announce a new scientific publication in the journal Cell Research.Read more [+]
Publication
Fluofarma cited in a Biocompare featured article “Flow Cytometry Gets a Makeover”Read more [+]
Press Release
Roche adopts Fluofarma’s high-content screening platform.Read more [+]
Scientific Publication
Fluofarma is glad to announce a new scientific publication in the journal "Analytical Chemistry".Read more [+]
ECCP 2010
Fluofarma will be attending the European Cancer Cluster Partnering 2010 in Oslo, from September 15th to 17th.Read more [+]
BIO-Connexion Congress
Fluofarma will be attending the Bio-Connexion Congress in Paris, from October 6th to 7th.Read more [+]
22nd EORTC-NCI-AACR symposium
Fluofarma will be exhibitor at the 22nd EORTC-NCI-AACR symposium in Berlin from November 16th to 19th.Read more [+]